Posts tagged breast cancer

The global death toll from cancer rose to 8.2 million in 2012 with sharp rises in breast cancer as the disease tightened its grip in developing nations struggling to treat an illness driven by Western lifestyles.

The global death toll from cancer rose to 8.2 million in 2012 with sharp rises in breast cancer as the disease tightened its grip in developing nations struggling to treat an illness driven by Western lifestyles.

AstraZeneca’s Anastrozole (Arimidex) reduced the risk of breast cancer by 53% in high-risk postmenopausal women, a primary prevention trial showed

AstraZeneca’s Anastrozole (Arimidex) reduced the risk of breast cancer by 53% in high-risk postmenopausal women, a primary prevention trial showed

A study long used to establish causal links between hormone replacement  therapy (HRT) and breast cancer is severely flawed, a group of  epidemiologists have charged.

A study long used to establish causal links between hormone replacement therapy (HRT) and breast cancer is severely flawed, a group of epidemiologists have charged.

Tamoxifen Gives 15-Year Breast Cancer Protection

Five years of tamoxifen treatment cuts a woman’s 15-year risk of breast cancer death by about a third, with or without chemotherapy treatment. The drug prevents recurrences and may actually cure patients."Substantially reduced mortality rates for breast cancer continue well beyond year 10, as a delayed effect of the greatly reduced [breast cancer] recurrence rates during years 0 to 9 [after about five years of tamoxifen therapy]," report Christina Davies, MD, and colleagues in the international Early Breast Cancer Trialists’ Collaborative Group. Read more here.

Mammogram Technology May Be Doing More Harm than Good

New mammogram software technology failed to improve breast cancer detection and also increased a woman’s risk of being told she had an abnormal mammogram when she was, in fact, cancer free."Women should probably understand that [computer-aided detection] is probably being used to interpret their mammogram and that it’s probably not helping detect breast cancer earlier," says Joshua J. Fenton, M.D., the lead author of both studies and an assistant professor of family and community medicine at the University of California at Davis School of Medicine, in Sacramento.
Read more here.

Roche Gears Up to Seek Approval on Breast Cancer Drug

The Swiss drug giant met the primary goal of a pivotal trial for a combination therapy against HER2-positive breast cancer.  When given experimental antibody pertuzumab with Herceptin and the chemo drug docetaxel, patients did better than those who were on Herceptin and chemotherapy alone. 

Read more here.

Medicare to Keep Paying for Avastin

Medicare will continue to pay for Avastin to treat metastatic breast cancer, even if the FDA decides to remove that indication from the drug, a spokesman for the Centers for Medicare and Medicaid Services (CMS) said. Since the FDA announced that the breast cancer indicator should be removed, patients worried that their insurance companies would not pay for the $8,000 per month medication, but Medicare assured that it would not back out on patients needing the drug.

Read more here.

FDA Panel Rejects Avastin Use

Health regulators delivered the controversial decision to reject the use of Avastin as health institutions conduct more studies on the drug. Maker of the drug, Roche Holding may lose close to $1 billion in revenue. But more importantly, some advanced stage breast cancer patients are outraged.

“What do you want us to take!? We have nothing else!” shouted Christi Turnage, of Madison, Miss. Turnage said her cancer has been undetectable for more than two years since starting therapy with Avastin, The Associate Press reported.

Read more about the decision here